KDx Diagnostics, a pioneering medical device company, announced on Thursday that it entered into strategic collaborations with leading distributors in Europe.
The collaboration indicates a significant milestone for KDx as the company continues with its aim to make early and accurate bladder cancer detection accessible globally.
The company's newly established distribution partners in Europe include LabForce AG, covering Switzerland, and MCT Lifesciences, covering United Kingdom.
SHL Telemedicine introduces SmartHeart direct-to-consumer membership plan
Broncus Hangzhou signs Equity Transfer Agreement with Hangzhou Jingliang shareholders
Bracco signs long-term partnership with ulrich GmbH
L&T Technology Services plans to revolutionise medical imaging in collaboration with NVIDIA
Eli Lilly to build new high-tech manufacturing site in Germany
Teva Pharmaceuticals secures FDA approval for generic Forteo (teriparatide injection)
Zymo Research's SafeCollect Saliva Collection Kit receives US FDA approval
Kanabo Group extends contract with major UK retailer
Biodesix enhances Nodify Lung testing with Tasso+ blood draw method
Byotrol unveils PROCESSUS instrument decontamination system
Integrum plans FDA PMA submission for OPRA in transhumeral amputations
Telix and Mauna Kea Technologies expand collaboration in urologic oncology surgery
Egetis secures exclusive licence agreement with Fujimoto for Emcitate development in Japan
KDx Diagnostics enters into strategic collaborations with leading distributors in Europe